AU2021318237A1 - Aqueous composition - Google Patents

Aqueous composition Download PDF

Info

Publication number
AU2021318237A1
AU2021318237A1 AU2021318237A AU2021318237A AU2021318237A1 AU 2021318237 A1 AU2021318237 A1 AU 2021318237A1 AU 2021318237 A AU2021318237 A AU 2021318237A AU 2021318237 A AU2021318237 A AU 2021318237A AU 2021318237 A1 AU2021318237 A1 AU 2021318237A1
Authority
AU
Australia
Prior art keywords
mass
aqueous composition
acid
salt
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2021318237A
Other languages
English (en)
Inventor
Saeko Hayashi
Akiko Kita
Ozora Kubo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rohto Pharmaceutical Co Ltd
Original Assignee
Rohto Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rohto Pharmaceutical Co Ltd filed Critical Rohto Pharmaceutical Co Ltd
Publication of AU2021318237A1 publication Critical patent/AU2021318237A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Ophthalmology & Optometry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2021318237A 2020-07-30 2021-07-30 Aqueous composition Pending AU2021318237A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020-129730 2020-07-30
JP2020129730 2020-07-30
PCT/JP2021/028441 WO2022025281A1 (ja) 2020-07-30 2021-07-30 水性組成物

Publications (1)

Publication Number Publication Date
AU2021318237A1 true AU2021318237A1 (en) 2023-03-09

Family

ID=80036439

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2021318237A Pending AU2021318237A1 (en) 2020-07-30 2021-07-30 Aqueous composition

Country Status (9)

Country Link
US (1) US20230285564A1 (https=)
EP (1) EP4176881A4 (https=)
JP (1) JPWO2022025281A1 (https=)
KR (1) KR20230047401A (https=)
CN (1) CN116568286A (https=)
AU (1) AU2021318237A1 (https=)
CA (1) CA3190313A1 (https=)
TW (1) TW202220659A (https=)
WO (1) WO2022025281A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220044288A (ko) * 2019-08-07 2022-04-07 로토 세이야쿠 가부시키가이샤 누액 분비 촉진용 안과 조성물
CN119367282A (zh) * 2019-12-27 2025-01-28 乐敦制药株式会社 水性组合物
EP4176882A4 (en) * 2020-07-30 2024-01-10 Rohto Pharmaceutical Co., Ltd. AQUEOUS COMPOSITION

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011225626A (ja) * 2001-02-01 2011-11-10 Rohto Pharmaceutical Co Ltd 点眼剤
PT1905453E (pt) * 2005-07-13 2012-12-04 Santen Pharmaceutical Co Ltd Composição conservante para utilização oftálmica
AU2007227091B2 (en) * 2006-03-17 2013-02-07 Johnson & Johnson Vision Care, Inc. Stabilized ophthalmic compositions comprising oxidatively unstable components
WO2008093358A2 (en) * 2007-01-29 2008-08-07 Sun Pharmaceutical Industries Limited Aqueous topical solution containing olopatadine
EP2265252A2 (en) * 2008-02-19 2010-12-29 Marvel Lifesciences Limited Ophthalmic preparation containing a pyridinol derivate
JP6427497B2 (ja) * 2013-10-21 2018-11-21 日本たばこ産業株式会社 眼疾患の治療剤又は予防剤
CA2991020A1 (en) 2015-07-07 2017-01-12 Japan Tobacco Inc. Method for producing 7h-pyrrolo[2, 3-d]pyrimidine derivative and intermediate thereof
TWI790218B (zh) 2016-12-21 2023-01-21 日商日本煙草產業股份有限公司 7Ｈ－吡咯并[2,3－ｄ]嘧啶衍生物的製造方法及其共結晶
KR20220044288A (ko) * 2019-08-07 2022-04-07 로토 세이야쿠 가부시키가이샤 누액 분비 촉진용 안과 조성물

Also Published As

Publication number Publication date
EP4176881A4 (en) 2024-07-31
JPWO2022025281A1 (https=) 2022-02-03
US20230285564A1 (en) 2023-09-14
TW202220659A (zh) 2022-06-01
EP4176881A1 (en) 2023-05-10
CN116568286A (zh) 2023-08-08
CA3190313A1 (en) 2022-02-03
WO2022025281A1 (ja) 2022-02-03
KR20230047401A (ko) 2023-04-07

Similar Documents

Publication Publication Date Title
JP7447176B2 (ja) ジクアホソル含有点眼液
AU2021318237A1 (en) Aqueous composition
CA3190310A1 (en) Aqueous composition
KR20230141882A (ko) 아트로핀-함유 수성 조성물
JP2025019313A (ja) 涙液分泌促進用眼科組成物
US20250288575A1 (en) Eye drop composition for prevention or treatment of ophthalmic diseases and preparation method therefor
JP2025146991A (ja) 水性組成物
JP7617031B2 (ja) 水性組成物
JP3146218B2 (ja) 点眼剤
JP5753958B2 (ja) 澄明な水性液剤
US20060073172A1 (en) Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure
BR112020024481A2 (pt) formulações/composições compreendendo ibrutinib
HK40091721A (zh) 水性组合物
JP5489581B2 (ja) プラノプロフェン含有水性組成物
HK40091389A (zh) 水性组合物
EP4534081A1 (en) Ophthalmic composition
HK40066213A (zh) 泪液分泌促进用眼科组合物
WO2024204749A1 (ja) 眼科組成物
EP4534082A1 (en) Ophthalmic composition
JP2012224629A (ja) ペミロラストを含有する安定な水性組成物
HK40003059B (zh) 含有阿托品的水性组合物